A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose
Status:
COMPLETED
Trial end date:
2025-05-17
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the routes and rate of elimination and recovery of total radioactivity (TRA) and characterize the Pharmacokinetic (PK) of VX-993 after a single oral dose of 14C-VX-993.